255 related articles for article (PubMed ID: 1708566)
1. [Effects on bone marrow during stimulation of hematopoietic stem cells with recombinant human interleukin-3].
Falk S; Seipelt G; Ganser A; Hoelzer D; Stutte HJ; Hübner K
Verh Dtsch Ges Pathol; 1990; 74():111-5. PubMed ID: 1708566
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow findings after treatment with recombinant human interleukin-3.
Falk S; Seipelt G; Ganser A; Ottmann OG; Hoelzer D; Stutte HJ; Hübner K
Am J Clin Pathol; 1991 Mar; 95(3):355-62. PubMed ID: 1996545
[TBL] [Abstract][Full Text] [Related]
3. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
Betticher DC; Huxol H; Müller R; Speck B; Nissen C
Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
[TBL] [Abstract][Full Text] [Related]
4. Clinical results with recombinant human interleukin-3.
Ganser A
Cancer Invest; 1993; 11(2):212-8. PubMed ID: 8462022
[No Abstract] [Full Text] [Related]
5. [In vitro and in vivo effects of recombinant human interleukin-3 on hematopoietic progenitor cells].
Seipelt G; Ottmann OG; Ganser A; Eder M; Lindemann A; Falk S; Stutte HJ; Hübner K; Mertelsmann R; Hoelzer D
Verh Dtsch Ges Pathol; 1990; 74():116-9. PubMed ID: 1708567
[TBL] [Abstract][Full Text] [Related]
6. In vivo recruitment of GM-CSF-response myelopoietic progenitor cells by interleukin-3 in aplastic anemia.
Herrmann F; Lindemann A; Raghavachar A; Heimpel H; Mertelsmann R
Leukemia; 1990 Oct; 4(10):671-2. PubMed ID: 2214870
[TBL] [Abstract][Full Text] [Related]
7. Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemia.
Gore SD; Weng LJ; Jones RJ; Cowan K; Zilcha M; Piantadosi S; Burke PJ
Clin Cancer Res; 1995 Mar; 1(3):295-303. PubMed ID: 9815985
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-3 in hematology and oncology: current state of knowledge and future directions.
Mangi MH; Newland AC
Cytokines Cell Mol Ther; 1999 Jun; 5(2):87-95. PubMed ID: 10515681
[TBL] [Abstract][Full Text] [Related]
9. A phase I/II study of interleukin-3 in patients with aplastic anemia and myelodysplasia.
Nimer SD; Paquette RL; Ireland P; Resta D; Young D; Golde DW
Exp Hematol; 1994 Aug; 22(9):875-80. PubMed ID: 8062886
[TBL] [Abstract][Full Text] [Related]
10. Results of phase I/II trials with recombinant human interleukin-3.
Ganser A; Ottmann OG; Seipelt G; Eder M; Geissler G; Merget R; Maurer A; Falk S; Lindemann A; Herrmann F
Biotechnol Ther; 1991; 2(3-4):313-25. PubMed ID: 1845133
[No Abstract] [Full Text] [Related]
11. Aplastic anemia and monosomy 7-associated dysmegakaryocytopoiesis.
Dolan MM; Singleton TP; Neglia J; Cioc A
Am J Clin Pathol; 2006 Dec; 126(6):925-30. PubMed ID: 17074689
[TBL] [Abstract][Full Text] [Related]
12. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
[TBL] [Abstract][Full Text] [Related]
13. Clinical use of hematopoietic growth factors.
Löwenberg B; Dale DC; Sheridan WP
Rev Invest Clin; 1994 Apr; Suppl():33-40. PubMed ID: 7886306
[No Abstract] [Full Text] [Related]
14. [In vitro proliferation and differentiation of bone marrow stem cells of aplastic anemia patients].
Chen G; Shao Z; Jia H
Zhonghua Xue Ye Xue Za Zhi; 1999 Oct; 20(10):529-31. PubMed ID: 11721400
[TBL] [Abstract][Full Text] [Related]
15. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
16. Preclinical and clinical evaluation of interleukin 3.
Ganser A; Ottmann OG; Seipelt G; Hess U; Geissler G; Merget R; Falk S; Maurer A; Eder M; Hoelzer D
Behring Inst Mitt; 1991 Dec; (90):50-61. PubMed ID: 1801691
[No Abstract] [Full Text] [Related]
17. Deficiency of CD34+ c-kit+ and CD34+38- hematopoietic precursors in aplastic anemia after immunosuppressive treatment.
Manz CY; Nissen C; Wodnar-Filipowicz A
Am J Hematol; 1996 Aug; 52(4):264-74. PubMed ID: 8701944
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic progenitor cells in the blood and bone marrow in various hematologic disorders.
Issaragrisil S; U-pratya Y; Yimyam M; Pakdeesuwan K; Khuhapinant A; Muangsup W; Pattanapanyasat K
Stem Cells; 1998; 16 Suppl 1():123-8. PubMed ID: 11012154
[TBL] [Abstract][Full Text] [Related]
19. [Primary myelodysplastic syndromes].
Brohée D
Rev Med Brux; 1988 Sep; 9(6):327-33. PubMed ID: 3051250
[No Abstract] [Full Text] [Related]
20. Prevention of acute chemotherapy-induced death in mice by recombinant human interleukin 1: protection from hematological and nonhematological toxicities.
Damia G; Komschlies KL; Futami H; Back T; Gruys ME; Longo DL; Keller JR; Ruscetti FW; Wiltrout RH
Cancer Res; 1992 Aug; 52(15):4082-9. PubMed ID: 1638519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
